OCUGEN, INC. Earnings Per Share (Basic)
OCUGEN, INC. (OCGN) reported Earnings Per Share (Basic) of -$0.07 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-08-06
- OCUGEN, INC. earnings per share, basic for the quarter ending 2026-06-30 was -$0.07.
- OCUGEN, INC. earnings per share, basic for the quarter ending 2026-03-31 was -$0.06.
- OCUGEN, INC. earnings per share, basic for the quarter ending 2025-06-30 was -$0.05.
- OCUGEN, INC. earnings per share, basic for the quarter ending 2025-03-31 was -$0.05.
- OCUGEN, INC. earnings per share, basic for fiscal 2023 was -$0.26.
- OCUGEN, INC. earnings per share, basic for fiscal 2022 was -$0.40.
- OCUGEN, INC. earnings per share, basic for fiscal 2021 was -$0.30.
- OCUGEN, INC. earnings per share, basic for fiscal 2020 was -$0.31.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 3 month as first filed | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 6 month as first filed | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 9 month as first filed | Earnings Per Share, Basic 12 month | Earnings Per Share, Basic 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$0.07 10-Q · filed 2026-08-06 | -$0.13 10-Q · filed 2026-08-06 | ||||||
| 2026-03-31 | -$0.06 10-Q · filed 2026-05-08 | |||||||
| 2025-06-30 | -$0.05 10-Q · filed 2026-08-06 | -$0.10 10-Q · filed 2026-08-06 | ||||||
| 2025-03-31 | -$0.05 10-Q · filed 2026-05-08 | |||||||
| 2024-06-30 | -$0.04 10-Q · filed 2024-08-08 | -$0.09 10-Q · filed 2024-08-08 | -$0.12 derived: net income ÷ weighted average shares · filed 2024-08-08 | -$0.18 derived: net income ÷ weighted average shares · filed 2024-08-08 | ||||
| 2024-03-31 | -$0.05 10-Q · filed 2024-05-14 | -$0.08 derived: net income ÷ weighted average shares · filed 2024-05-14 | -$0.14 derived: net income ÷ weighted average shares · filed 2024-05-14 | -$0.23 derived: net income ÷ weighted average shares · filed 2024-08-08 | ||||
| 2023-12-31 | -$0.04 derived: net income ÷ weighted average shares · filed 2024-04-16 | -$0.09 derived: net income ÷ weighted average shares · filed 2024-04-16 | -$0.19 derived: net income ÷ weighted average shares · filed 2024-08-08 | -$0.26 10-K · filed 2024-04-16 | ||||
| 2023-09-30 | -$0.05 10-K · filed 2024-04-16 | -$0.06 10-Q · filed 2023-11-09 | -$0.15 derived: net income ÷ weighted average shares · filed 2024-08-08 | -$0.22 10-K · filed 2024-04-16 | -$0.35 derived: net income ÷ weighted average shares · filed 2024-08-08 | |||
| 2023-06-30 | -$0.10 10-Q · filed 2024-08-08 | -$0.17 10-Q · filed 2024-08-08 | -$0.30 derived: net income ÷ weighted average shares · filed 2024-08-08 | -$0.40 derived: net income ÷ weighted average shares · filed 2024-08-08 | ||||
| 2023-03-31 | -$0.08 10-Q · filed 2024-05-14 | -$0.07 10-Q · filed 2023-05-05 | -$0.20 derived: net income ÷ weighted average shares · filed 2024-05-14 | -$0.30 derived: net income ÷ weighted average shares · filed 2024-05-14 | ||||
| 2022-12-31 | -$0.12 derived: net income ÷ weighted average shares · filed 2024-04-16 | -$0.23 derived: net income ÷ weighted average shares · filed 2024-04-16 | -$0.40 10-K · filed 2024-04-16 | -$0.38 10-K · filed 2023-02-28 | ||||
| 2022-09-30 | -$0.11 10-K · filed 2024-04-16 | -$0.10 10-Q · filed 2022-11-08 | -$0.30 10-K · filed 2024-04-16 | -$0.28 10-Q · filed 2022-11-08 | ||||
| 2022-06-30 | -$0.10 10-K · filed 2024-04-16 | -$0.09 10-Q · filed 2022-08-05 | -$0.19 10-K · filed 2024-04-16 | -$0.18 10-Q · filed 2022-08-05 | ||||
| 2022-03-31 | -$0.09 10-K · filed 2024-04-16 | |||||||
| 2021-12-31 | -$0.07 derived: net income ÷ weighted average shares · filed 2023-02-28 | -$0.13 derived: net income ÷ weighted average shares · filed 2023-02-28 | -$0.26 derived: net income ÷ weighted average shares · filed 2023-02-28 | -$0.30 10-K · filed 2023-02-28 | ||||
| 2021-09-30 | -$0.05 10-Q · filed 2022-11-08 | -$0.19 derived: net income ÷ weighted average shares · filed 2022-11-08 | -$0.23 10-Q · filed 2022-11-08 | -$0.25 derived: net income ÷ weighted average shares · filed 2022-11-08 | ||||
| 2021-06-30 | -$0.13 10-Q · filed 2022-08-05 | -$0.17 10-Q · filed 2022-08-05 | -$0.20 derived: net income ÷ weighted average shares · filed 2022-08-05 | -$0.27 derived: net income ÷ weighted average shares · filed 2022-08-05 | ||||
| 2021-03-31 | -$0.04 10-Q · filed 2022-05-06 | -$0.06 derived: net income ÷ weighted average shares · filed 2022-05-06 | -$0.13 derived: net income ÷ weighted average shares · filed 2022-05-06 | -$0.26 derived: net income ÷ weighted average shares · filed 2022-05-06 | ||||
| 2020-12-31 | -$0.02 derived: net income ÷ weighted average shares · filed 2022-02-28 | -$0.09 derived: net income ÷ weighted average shares · filed 2022-02-28 | -$0.23 derived: net income ÷ weighted average shares · filed 2022-02-28 | -$0.31 10-K · filed 2022-02-28 | ||||
| 2020-09-30 | -$0.07 10-Q · filed 2021-11-09 | -$0.24 derived: net income ÷ weighted average shares · filed 2021-11-09 | -$0.33 10-Q · filed 2021-11-09 | |||||
| 2020-06-30 | -$0.19 10-Q · filed 2021-08-06 | -$0.30 10-Q · filed 2021-08-06 | ||||||
| 2019-12-31 | -$1.46 10-K · filed 2022-02-28 | |||||||
| 2018-12-31 | -$0.18 derived: net income ÷ weighted average shares · filed 2020-03-27 | $0.00 derived: net income ÷ weighted average shares · filed 2020-03-27 | -$0.23 10-K · filed 2019-03-22 | |||||
| 2018-09-30 | $0.36 10-Q · filed 2018-11-08 | -$0.27 10-Q · filed 2018-11-08 | ||||||
| 2017-12-31 | -$0.25 derived: net income ÷ weighted average shares · filed 2019-03-22 | -$0.48 derived: net income ÷ weighted average shares · filed 2019-03-22 | -$0.99 10-K · filed 2019-03-22 | |||||
| 2017-09-30 | -$0.23 10-Q · filed 2018-11-08 | -$0.74 10-Q · filed 2018-11-08 | ||||||
| 2016-12-31 | -$0.97 10-K · filed 2018-03-15 | |||||||
| 2015-12-31 | -$2.42 10-K · filed 2017-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cabaletta Bio, Inc. (CABA) | United States | $0.365B | -2.81 |
| Artiva Biotherapeutics, Inc. (ARTV) | United States | $0.367B | |
| FENNEC PHARMACEUTICALS INC. (FENC) | United States | $0.371B | -115.85 |
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| Century Therapeutics, Inc. (IPSC) | United States | $0.306B | -4.02 |
| SAB Biotherapeutics, Inc. (SABS) | United States | $0.306B | -25.49 |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |
| X4 Pharmaceuticals, Inc (XFOR) | United States | $0.297B | -4.99 |
| Inhibikase Therapeutics, Inc. (IKT) | United States | $0.296B | -4.44 |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B |